CLINSOL contains clindamycin, a lincosamide antibiotic active against a range of gram-positive aerobic microorganisms and anaerobic bacteria. The manufacturer lists respiratory tract infections, skin and soft tissue infections, intra-abdominal infections, bloodstream infections, and female reproductive tract infections among its uses.
How it works:
Who may be prescribed this medicine:
Clindamycin acts primarily as a bacteriostatic antibiotic by binding to the 50S subunit of the bacterial ribosome and inhibiting bacterial protein synthesis required for bacterial growth and reproduction.
Clindamycin has been extensively studied as an antibacterial medicine and has been used clinically for many years in the treatment of serious infections. Clinical evidence supports its activity against a range of anaerobic and gram-positive bacterial infections. However, it should not be used for viral infections or without an appropriate medical indication.
Research and prescribing information place particular emphasis on the risk of Clostridioides difficile-associated diarrhea. Antibiotic-associated diarrhea can occur during treatment or after treatment has ended and, in severe cases, may develop into pseudomembranous colitis. For this reason, systemic clindamycin is generally reserved for serious infections when less toxic alternatives are not appropriate.
Clindamycin is used to treat serious infections caused by susceptible microorganisms.
Potential indications include:
The medicine is intended for bacterial infections and does not treat viral illnesses. The suspected pathogen and its susceptibility to the antibiotic should be considered before treatment.
The capsules should be taken orally exactly as prescribed by a healthcare professional. The dose and duration depend on the type and severity of the infection, the susceptibility of the organism, and the patient's age and medical condition. The capsule should be swallowed whole with an adequate amount of water. The prescribed dose or treatment duration should not be changed, and treatment should not be discontinued without medical advice.
Severe or persistent diarrhea during or after treatment requires medical attention because C. difficile-associated infection can be serious.
